BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

Volition's global strategy is to implement similar agreements with multiple companies to ensure the broadest possible accessibility to the Nu.Q® ...

December 17, 2021 | News

Everest Medicines to treat Triple-Negative Breast Cancer in South Korea

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...

December 15, 2021 | News

Clarity and Cardinal Health to address the growing needs in oncology

Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growin...

December 03, 2021 | News

World-first lung cancer screening facility increases chance of cure

The truck will be fitted with the latest technology, integrating imaging, breath and blood biomarker screening, as part of a $2 million Australian Can...

December 01, 2021 | Influencers

Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech

The preclinical research also demonstrated Zantrene's ability to synergise with existing anthracyclines to better kill breast cancer cells. Due to signi...

November 22, 2021 | News

Carina Biotech and CellVec advances clinical trials, making strides for colorectal cancer treatment

Singapore-based viral vector CDMO supplies lentiviruses to Carina Biotech, advancing first in-human clinical trial for bowel cancer treatment ...

November 10, 2021 | News

Veracyte Announces Immunoscore Colon Cancer Test

Veracyte, Inc. today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO1 Clinical Practice Guideli...

November 08, 2021 | News

Freenome Shows Continued Leadership in Colorectal Cancer Research

Freenome, a privately held biotech company, presented new research at the American College of Gastroenterology (ACG) annual meeting that underscores their ...

October 26, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

October 26, 2021 | News

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

Everest Medicines to treat Triple-Negative Breast Cancer in South Korea

Clarity and Cardinal Health to address the growing needs in oncology

World-first lung cancer screening facility increases chance of cure

Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech

Carina Biotech and CellVec advances clinical trials, making strides for colorectal cancer treatment

Veracyte Announces Immunoscore Colon Cancer Test

Freenome Shows Continued Leadership in Colorectal Cancer Research

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

Rakuten,Karkinos Healthcare Announce Partnership to Expand Novel Cancer Care in India

Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

Merck and Eisai Receive Positive EU CHMP Opinions

Chinese Researcher Releases Latest Research Results on Early Screening for Multiple Cancers

Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers

Stay Connected